Business
Liberty Announces Listed Issuer Financing Exemption (LIFE) Private Placement of Units
Liberty Announces Listed Issuer Financing Exemption (LIFE) Private Placement of Units C...
About this update from Liberty Defense Holdings Ltd.
[{"type":"text","content":"\n \n \n \n Liberty Announces Listed Issuer Financing Exemption (LIFE) Private Placement of Units\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n /NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR DISSEMINATION IN\n \n THE UNITED STATES\n \n /\n \n \n \n \n \n VANCOUVER, BC\n \n and\n \n WILMINGTON, Mass.\n \n \n ,\n \n \n Sept. 7, 2023\n \n \n /CNW/ -\n \n Liberty Defense Holdings Ltd.\n \n (\"\n \n Liberty\n \n \" or the \"\n \n Company\n \n \") (TSXV: SCAN) (OTCQB: LDDFF) (FRANKFURT: LD2), a leading technology provider of AI-based next generation detection solutions for concealed weapons and threats, is pleased to announce that it has entered into an engagement letter agreement with Canaccord Genuity Corp. (the \"\n \n Lead Agent\n \n \") pursuant to which the Lead Agent, on behalf of a syndicate of agents (collectively, the \"\n \n Agents\n \n \") will act as lead agent for the Company on a 'commercially reasonable efforts' agency basis in connection with a private placement of a minimum of 10,000,000 up to a maximum of 25,000,000 units (the \"\n \n Units\n \n \") of the Company at a price of\n \n C$0.20\n \n per Unit (the \"\n \n Offering Price\n \n \") for gross proceeds to the Company of a minimum of\n \n C$2,000,000\n \n up to a maximum of\n \n $5,000,000\n \n (the \"\n \n Offering\n \n \"). The Offering has been structured to take advantage of the listed issuer financing exemption whereby securities of the Company issued pursuant to the Offering will be freely tradeable equity securities not subject to any hold period (see below).\n \n \n Each Unit will consist of one common share in the capital of the Company (a \"\n \n Common Share\n \n \") and one Common Share purchase warrant (a \"\n \n Warrant\n \n \"). Each Warrant will entitle the holder thereof to purchase one Common Share of the Company (a \"\n \n Warrant Share\n \n \") for a period of 36 months following the closing date of the Offering at an exercise price of\n \n C$0.30\n \n per Warrant Share.\n \n \n Subject to compliance with app...